News

[2] TransCon refers to "transient conjugation". Ascendis Pharma's innovative technology platform to create new therapies designed to potentially optimise therapeutic effect, including improving ...
[2] TransCon refers to "transient conjugation". Ascendis Pharma's innovative technology platform to create new therapies designed to potentially optimise therapeutic effect, including improving ...
However, analysts believe that Ascendis’ TransCon CNP could outperform existing treatments due to superior efficacy and convenience. The company’s TransCon technology platform is viewed as a ...
At the heart of the agreement is an exclusive worldwide license to Copenhagen-based Ascendis' TransCon technology platform, which involves adding linker and carrier molecules to turn established ...
Eli Lilly’s PTH-based osteoporosis therapy Forteo (teriparatide) is also used off-label in some hypoparathyroidism patients and, while Ascendis Pharma’s TransCon PTH (palopegteriparatide ...
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.
Wellness group Ascendis Health has been making a recovery from crippling debt, but the threat of business rescue still hangs over its head. Ascendis has managed to cut it debt down from R6.7 billion ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...
Artificial intelligence technology bellwether Nvidia overcame a wave of tariff-driven turbulence to deliver another quarter of robust growth amid feverish demand for its high-powered chips that ...
Donald Trump responds to Elon Musk's 'disappointing' remark on: 'I'm not happy about...' President Trump defended the 'One Big Beautiful Bill' after Elon Musk criticized its high cost and impact ...